A scoping review of thresholds for responder and time-to-event analysis of patient-reported outcomes in breast cancer trials.
Sign Up to like & getrecommendations! Published in 2025 at "British journal of clinical pharmacology"
DOI: 10.1002/bcp.70341
Abstract: Patient-reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time-to-event analyses, which depend on predefined thresholds to determine clinically… read more here.
Keywords: time event; breast cancer; responder time;